Advanced Renal Cell Cancer Combination ImmunoThErapy Clinical Trial
Condition: Advanced Renal Cell Carcinoma Interventions: Drug: Botensilimab; Drug: Balstilimab; Drug: Ipilimumab; Drug: Nivolumab Sponsors: Michael B. Atkins, MD; Agenus Inc.; Georgetown University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Clinical Trials | Immunotherapy | Kidney Cancer | Renal Cell Carcinoma | Research | Yervoy